Product: Precision Insights

Filter

Thought Leadership

Product

Organization

Precision Insights
Data from NantHealth’s GPS Cancer platform reveals increased...
NantHealth Presented These Findings at the ASCO 2020 Gastrointestinal Cancers Symposium San Francisco, CA – January 25, 2020: NantHealth, Inc....
Precision Insights
Precision Insights
NantHealth Presents Research Demonstrating Real World Evidence of...
Eviti Connect study showed an increase in clinical uptake of practice-changing data San Antonio, TX – December 11, 2019 –...
Precision Insights
Precision Insights
NantHealth Announces FDA Marketing Authorization of Omics CoreSM:...
Landmark FDA clearance of whole exome sequencing in vitro diagnostic (IVD) test reporting overall tumor mutation burden (TMB) by sequencing...
Precision Insights
Precision Insights
NantHealth® and NantOmics to Present Evidence for Selective...
Results to be presented during the developmental immunotherapy and tumor immunobiology session at the American Society of Clinical Oncology (ASCO)...
Precision Insights
Precision Insights
NantHealth® and NantOmics to Present Data on Tumor...
Results to be presented during the cancer prevention, hereditary genetics and epidemiology session at the ASCO 2019 Annual Meeting CHICAGO,...
Precision Insights
Precision Insights
NantHealth® and Northwest Firefighters Benefits Trust (NWFFT) Join...
Culver City, CA – March 18, 2019 – NantHealth, Inc. (NASDAQ: NH),announced an agreement with Northwest Fire Fighters Benefits Trust (NWFFT), one...
Precision Insights
Precision Insights
NantHealth® and NantOmics to Reveal New Research Demonstrating...
Findings to be presented at the 2019 American Society of Clinical Oncology’s Genitourinary Cancers Symposium San Francisco and Culver City,...
Precision Insights
Precision Insights
NantHealth® and NantOmics to Reveal New Research at...
Findings demonstrate the need for comprehensive personalized tumor testing to deliver actionable insights and inform effective treatment plans  San Francisco,...
Precision Insights
Precision Insights
NantCell Announces New Celgene Investment
Immunotherapy Company Will Present Findings at the JP Morgan Healthcare Conference in San Francisco on January 7th Second Round Crossover Funding...
Precision Insights